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Objective Autoimmune diseases are characterised and regu-
larly diagnosed by the presence of autoantibodies to hetero-
geneous nuclear RNP (hnRNP) autoantigens. These proteins 
represent a group of autoantigens which are targeted by 
autoantibodies from patients with rheumatoid arthritis (RA), 
systemic lupus erythematosus (SLE) and mixed connective tis-
sue disease. The authors investigated a new member of the 
hnRNP family targeted by autoantibodies and tested a combi-
nation of hnRNPs in humans and animal models of infl amma-
tory rheumatic diseases
Methods Using protein macroarray the authors identi-
fi ed JKDBP in humans and animal models of infl ammatory 
rheumatic diseases. Autoantigens are produced in bacteria 
expressed purifi ed using His-tag and a Biotin-tag under native 
and denaturated conditions. Bacterially expressed recombi-
nant hnRNPs proteins were used in Elisa for confi rming the 
data obtained by macroarray. Anti-hnRNP-A/B and hnRNP D 
proteins were detected in a newly developed Elisa with patient 
sera and sera from animal model of SLE and RA.
Results Autoantibodies to hnRNPDL proteins were detected 
in 46% of patients with SLE, 21% of patients with RA, 17% 
of MRl lpr mice, 50% of SKG Mice and <10% of patients with 
other rheumatic disorders. The auoantibody response is depen-
dent on both TLR7 and TLR9 costimulation tested with sera 
from TLR7, TLR9 defi cient and double-defi cient mice with 
an MRL-lpr/lpr background. Using a combination of three 
hnRNPs A2/D/DL, 76% of RA, 84% of SLE sera and 87% SKG 
mice with arthritis, can be detected. Using citrullinated pep-
tides out of a mutated form of hnRNPA3 and hnRNPA2/D/
DL, 94% out of 68 RA sera can be identifi ed. Moreover already 
identifi ed autoantigens like hnRNP A2/A3/D, identifi ed 
epitopes as well as identifi ed citrullinated peptides (deduced 
citrullinated peptides thereof) were used to identify patterns 
associated with disease severity.
Conclusion These data identify hnRNPDL proteins as novel 
autoantigen in RA, SLE and in animal models of infl amma-
tory rheumatic diseases. The anti-hnRNPDL antibody is Toll 
7 and 9 dependent generated and in combination with other 
hnRNPs D/A2/A3 they can be used to partially close the sen-
sitivity gap left by rheumatoid factor and anti CCP antibodies 
in RA.
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